No Data
Pfizer's Colorectal Cancer Combo Therapy Gains Accelerated Approval From FDA
TD Cowen Maintains Pfizer(PFE.US) With Hold Rating, Maintains Target Price $32
SA Asks: Which Big Pharmas Are Likely to Announce Big M&A Deals?
Why Pfizer Inc. (PFE) Is One of the Best Stocks to Buy and Hold for 3 Years?
Pfizer Just Reassured Investors, but Is the Stock a Buy?
Pfizer Inc. (PFE) Is Among the Best Dividend Leaders to Buy According to Wall Street Analysts